Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Lymphoma 3Testicular Neoplasms 2Teratoma 2Vulvar Neoplasms 1Seminoma 1Recurrence 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Hemangioma, Capillary 1Hemangioma 1HIV Infections 1Central Nervous System Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Etoposide 1Electroacupuncture 1Carboplatin 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Ovarian Germ Cell Cancer × Bleomycin × Clear all
NCT00276718 2013-09-17

Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors

National Cancer Institute (NCI)

Phase NA Unknown
100 enrolled
CNSGenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡